Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arizona Chemical is a leading global producer of pine-based specialty chemicals and a pioneer in biorefining. The company refines crude tall oil and crude sulfate turpentine—renewable byproducts of the wood pulping process—into high-value products such as rosin esters, fatty acids, and terpenes. These bio-based materials are utilized across diverse sectors, including adhesives, road construction, and personal care, as well as providing intermediates for the pharmaceutical and fragrance industries. In 2016, Arizona Chemical was acquired by Kraton Corporation for $1.37 billion, integrating its extensive portfolio of sustainable chemical solutions into Kraton's global operations. The company remains a critical supplier of renewable alternatives to petroleum-derived products, supporting global sustainability initiatives. Its health-related portfolio includes phytosterols for nutritional supplements and specialized resins for topical drug delivery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arizona Chemical.